No one should ignore even a sharp tooth,” cautioned N. Mahathi, Professor, Oral Oncology and Maxillofacial Surgery, and a representative of the Isha Foundation. To support holistic recovery ...

Antibody drugs that target the PD-1 and VEGF pathways are in the ASCO spotlight, while doctors wrestle with how to use new ...

Vepdegestrant, an oral PROTAC, nearly doubles progression-free survival in ESR1-mutated, ER-positive advanced breast cancer, ...

Inflammation fuels the high rate of cancer in people over 50, researchers find, leading them to test anti-inflammatories like ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of ...

Body weight response with anamorelin in advanced non-small cell lung cancer (NSCLC) patients with anorexia/cachexia: Pooled analysis of two phase III trials. This is an ASCO Meeting Abstract from the ...

Exposure to secondhand smoke could increase the risk of developing oral cancer by 51 percent for individuals, according to a new meta-analysis of prior cancer studies, published in the journal Tobacco ...